# Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology

> **NCT03092518** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 27 (actual)

## Conditions studied

- Gastric Adenocarcinoma
- Esophagogastric Junction
- Gastric Cancer

## Interventions

- **PROCEDURE:** Surgery
- **DRUG:** Cisplatin
- **DRUG:** Mitomycin C
- **DRUG:** Sodium Thiosulfate
- **PROCEDURE:** Tumor Biopsy
- **DIAGNOSTIC_TEST:** CT C/A/P
- **DIAGNOSTIC_TEST:** PET-CT
- **DIAGNOSTIC_TEST:** MRI
- **DIAGNOSTIC_TEST:** EKG

## Key facts

- **NCT ID:** NCT03092518
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-05
- **Primary completion:** 2024-04-05
- **Final completion:** 2024-07-24
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03092518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03092518, "Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03092518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*